Compare BFRI & PTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFRI | PTLE |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 8.0M |
| IPO Year | 2021 | 2024 |
| Metric | BFRI | PTLE |
|---|---|---|
| Price | $0.82 | $0.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | 130.7K | ★ 3.4M |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $37,164,000.00 | ★ $91,415,732.00 |
| Revenue This Year | $9.70 | N/A |
| Revenue Next Year | $10.97 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.11 | N/A |
| 52 Week Low | $0.54 | $0.14 |
| 52 Week High | $1.87 | $15.78 |
| Indicator | BFRI | PTLE |
|---|---|---|
| Relative Strength Index (RSI) | 42.82 | 40.18 |
| Support Level | $0.77 | $0.15 |
| Resistance Level | $0.87 | $0.16 |
| Average True Range (ATR) | 0.07 | 0.01 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 59.46 | 16.94 |
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.